| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6392169980b946560a357d5ea652d6b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9a3e12b7e0c99a083640abea8473f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5175349a5712bcc8af168e32337d081 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-72 |
| filingDate |
2004-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93dff9630aabdcc065b818b941b2dde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb5e0bb3337bec2f6fc27a83116a1615 |
| publicationDate |
2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005023741-A2 |
| titleOfInvention |
Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
| abstract |
Cannabinoid derivatives are known for their functions in the central as well as peripheral nervous system. The present invention describes some novel (+)-cannabidiol (CBD) derivatives, and their selective activity in the peripheral and not in the central nervous system. Thus, it is an object of the invention to provide the use of (+)-CBD derivatives as analgesics, anti-inflammatory and anti-diarrheal agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022113071-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9517989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3071193-A4 |
| priorityDate |
2003-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |